Hydroxyethyl Starch Derivatives
"Hydroxyethyl Starch Derivatives" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups.
| Descriptor ID |
D006895
|
| MeSH Number(s) |
D09.301.915.500 D09.698.365.855.500
|
| Concept/Terms |
Hydroxyethyl Starch Derivatives- Hydroxyethyl Starch Derivatives
- Derivatives, Hydroxyethyl Starch
- Starch Derivatives, Hydroxyethyl
- Hydroxyethylated Starches
- Starches, Hydroxyethylated
- Starches, 2-Hydroxyethyl
- 2-Hydroxyethyl Starches
- Starches, 2 Hydroxyethyl
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyethyl Starch Derivatives".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyethyl Starch Derivatives".
This graph shows the total number of publications written about "Hydroxyethyl Starch Derivatives" by people in this website by year, and whether "Hydroxyethyl Starch Derivatives" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyethyl Starch Derivatives" by people in Profiles.
-
Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch. Transfusion. 2023 07; 63(7):1344-1353.
-
Pyruvate as a novel carrier of hydroxyethyl starch 130/0.4 may protect kidney in rats subjected to severe burns. J Surg Res. 2018 05; 225:166-174.
-
Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashion. Cytotherapy. 2012 Feb; 14(2):215-22.
-
Hetastarch and bleeding complications after coronary artery surgery. Chest. 2003 Oct; 124(4):1437-42.
-
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
-
A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant. 2003 Jun; 31(11):1043-51.
-
Augmentation of low-frequency ultrasound-induced clot disruption by hydroxyethyl starch is dependent on the duration and intensity of ultrasound exposure; an in vitro study. Ultrasound Med Biol. 2003 Mar; 29(3):483-6.
-
The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound. Cardiovasc Drugs Ther. 2001 Mar; 15(2):119-23.
-
Microparticle-containing oncotic solutions augment in-vitro clot disruption by ultrasound. Thromb Res. 2000 Jun 15; 98(6):549-57.
-
Management of hemorrhagic shock with hydroxyethyl starch, total-dose imferon infusion, and mass spectrophotometry. Crit Care Med. 1982 Jul; 10(7):484-5.